These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 9188471

  • 1. Signaling of type II oncostatin M receptor.
    Auguste P, Guillet C, Fourcin M, Olivier C, Veziers J, Pouplard-Barthelaix A, Gascan H.
    J Biol Chem; 1997 Jun 20; 272(25):15760-4. PubMed ID: 9188471
    [Abstract] [Full Text] [Related]

  • 2. Receptor subunit-specific action of oncostatin M in hepatic cells and its modulation by leukemia inhibitory factor.
    Wang Y, Robledo O, Kinzie E, Blanchard F, Richards C, Miyajima A, Baumann H.
    J Biol Chem; 2000 Aug 18; 275(33):25273-85. PubMed ID: 10854424
    [Abstract] [Full Text] [Related]

  • 3. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130.
    Hermanns HM, Radtke S, Haan C, Schmitz-Van de Leur H, Tavernier J, Heinrich PC, Behrmann I.
    J Immunol; 1999 Dec 15; 163(12):6651-8. PubMed ID: 10586060
    [Abstract] [Full Text] [Related]

  • 4. Activation of the Jak-Stat- and MAPK-pathways by oncostatin M is not sufficient to cause growth inhibition of human glioma cells.
    Halfter H, Postert C, Friedrich M, Ringelstein EB, Stögbauer F.
    Brain Res Mol Brain Res; 2000 Sep 15; 80(2):198-206. PubMed ID: 11038252
    [Abstract] [Full Text] [Related]

  • 5. Activation of Jak-Stat and MAPK2 pathways by oncostatin M leads to growth inhibition of human glioma cells.
    Halfter H, Friedrich M, Postert C, Ringelstein EB, Stögbauer F.
    Mol Cell Biol Res Commun; 1999 May 15; 1(2):109-16. PubMed ID: 10356359
    [Abstract] [Full Text] [Related]

  • 6. Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy.
    Podewski EK, Hilfiker-Kleiner D, Hilfiker A, Morawietz H, Lichtenberg A, Wollert KC, Drexler H.
    Circulation; 2003 Feb 18; 107(6):798-802. PubMed ID: 12591746
    [Abstract] [Full Text] [Related]

  • 7. Influence of subunit combinations on signaling by receptors for oncostatin M, leukemia inhibitory factor, and interleukin-6.
    Kuropatwinski KK, De Imus C, Gearing D, Baumann H, Mosley B.
    J Biol Chem; 1997 Jun 13; 272(24):15135-44. PubMed ID: 9182534
    [Abstract] [Full Text] [Related]

  • 8. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M.
    Schrell UM, Koch HU, Marschalek R, Schrauzer T, Anders M, Adams E, Fahlbusch R.
    J Neurosurg; 1998 Mar 13; 88(3):541-8. PubMed ID: 9488310
    [Abstract] [Full Text] [Related]

  • 9. Differential inhibition of IL-6-type cytokine-induced STAT activation by PMA.
    Terstegen L, Maassen BG, Radtke S, Behrmann I, Schaper F, Heinrich PC, Graeve L, Gatsios P.
    FEBS Lett; 2000 Jul 28; 478(1-2):100-4. PubMed ID: 10922477
    [Abstract] [Full Text] [Related]

  • 10. Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation.
    Mosley B, De Imus C, Friend D, Boiani N, Thoma B, Park LS, Cosman D.
    J Biol Chem; 1996 Dec 20; 271(51):32635-43. PubMed ID: 8999038
    [Abstract] [Full Text] [Related]

  • 11. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components.
    Stahl N, Boulton TG, Farruggella T, Ip NY, Davis S, Witthuhn BA, Quelle FW, Silvennoinen O, Barbieri G, Pellegrini S.
    Science; 1994 Jan 07; 263(5143):92-5. PubMed ID: 8272873
    [Abstract] [Full Text] [Related]

  • 12. Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal/osteoblastic cells.
    Bellido T, Stahl N, Farruggella TJ, Borba V, Yancopoulos GD, Manolagas SC.
    J Clin Invest; 1996 Jan 15; 97(2):431-7. PubMed ID: 8567964
    [Abstract] [Full Text] [Related]

  • 13. Cloning and characterization of a specific receptor for mouse oncostatin M.
    Lindberg RA, Juan TS, Welcher AA, Sun Y, Cupples R, Guthrie B, Fletcher FA.
    Mol Cell Biol; 1998 Jun 15; 18(6):3357-67. PubMed ID: 9584176
    [Abstract] [Full Text] [Related]

  • 14. Identification of a gp130 cytokine receptor critical site involved in oncostatin M response.
    Olivier C, Auguste P, Chabbert M, Lelièvre E, Chevalier S, Gascan H.
    J Biol Chem; 2000 Feb 25; 275(8):5648-56. PubMed ID: 10681548
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The carboxyl-terminal domains of gp130-related cytokine receptors are necessary for suppressing embryonic stem cell differentiation. Involvement of STAT3.
    Ernst M, Novak U, Nicholson SE, Layton JE, Dunn AR.
    J Biol Chem; 1999 Apr 02; 274(14):9729-37. PubMed ID: 10092661
    [Abstract] [Full Text] [Related]

  • 17. Interleukin-6 family of cytokines induced activation of different functional sites expressed by gp130 transducing protein.
    Chevalier S, Fourcin M, Robledo O, Wijdenes J, Pouplard-Barthelaix A, Gascan H.
    J Biol Chem; 1996 Jun 21; 271(25):14764-72. PubMed ID: 8662918
    [Abstract] [Full Text] [Related]

  • 18. Leptin receptor (OB-R) oligomerizes with itself but not with its closely related cytokine signal transducer gp130.
    Nakashima K, Narazaki M, Taga T.
    FEBS Lett; 1997 Feb 10; 403(1):79-82. PubMed ID: 9038364
    [Abstract] [Full Text] [Related]

  • 19. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.
    Schaper F, Gendo C, Eck M, Schmitz J, Grimm C, Anhuf D, Kerr IM, Heinrich PC.
    Biochem J; 1998 Nov 01; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795
    [Abstract] [Full Text] [Related]

  • 20. Signal transduction of IL-6, leukemia-inhibitory factor, and oncostatin M: structural receptor requirements for signal attenuation.
    Anhuf D, Weissenbach M, Schmitz J, Sobota R, Hermanns HM, Radtke S, Linnemann S, Behrmann I, Heinrich PC, Schaper F.
    J Immunol; 2000 Sep 01; 165(5):2535-43. PubMed ID: 10946280
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.